HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Deng Selected Research

C-terminal binding protein

2/2020Protocatechuic Aldehyde Represses Proliferation and Migration of Breast Cancer Cells through Targeting C-terminal Binding Protein 1.
1/2020CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells.
10/2018C-Terminal Binding Protein 1 Modulates Cellular Redox via Feedback Regulation of MPC1 and MPC2 in Melanoma Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Deng Research Topics

Disease

62Neoplasms (Cancer)
07/2022 - 04/2004
18Inflammation (Inflammations)
06/2022 - 06/2011
17Infections
02/2022 - 10/2007
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021 - 04/2013
12Neoplasm Metastasis (Metastasis)
07/2022 - 07/2015
12Respiratory Syncytial Virus Infections
01/2021 - 12/2011
11Lung Neoplasms (Lung Cancer)
01/2022 - 04/2013
11Huntington Disease (Huntington's Disease)
01/2019 - 06/2006
10Breast Neoplasms (Breast Cancer)
01/2022 - 06/2012
9Mitochondrial Diseases (Mitochondrial Disease)
09/2022 - 01/2019
8Neurodegenerative Diseases (Neurodegenerative Disease)
11/2022 - 08/2011
8Asthma (Bronchial Asthma)
06/2021 - 07/2010
8Osteoarthritis
01/2021 - 11/2012
8Alzheimer Disease (Alzheimer's Disease)
02/2020 - 04/2006
7Adenocarcinoma of Lung
01/2022 - 11/2013
7Colonic Neoplasms (Colon Cancer)
01/2022 - 04/2012
7Wounds and Injuries (Trauma)
01/2018 - 05/2014
7Respiratory Hypersensitivity
12/2017 - 06/2011
6Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 03/2011
6Hypoxia (Hypoxemia)
01/2021 - 10/2019
6Fetal Growth Retardation (Intrauterine Growth Retardation)
01/2020 - 11/2012
6Type 2 Diabetes Mellitus (MODY)
10/2016 - 01/2011
6Diabetic Retinopathy (Retinopathy, Diabetic)
10/2016 - 01/2011
5Carcinogenesis
03/2022 - 02/2014
5Pneumonia (Pneumonitis)
02/2022 - 04/2014
5Bronchiolitis
01/2020 - 07/2010
4Shock
03/2022 - 01/2022
4Hepatocellular Carcinoma (Hepatoma)
02/2021 - 12/2019
4Neuroblastoma
02/2020 - 12/2017
4Melanoma (Melanoma, Malignant)
01/2019 - 01/2011
4Body Weight (Weight, Body)
04/2015 - 01/2010
3Psoriasis (Pustulosis Palmaris et Plantaris)
06/2022 - 01/2018
3Hypertension (High Blood Pressure)
05/2022 - 07/2014
3Heart Failure
05/2022 - 07/2020
3Ischemic Stroke
03/2022 - 01/2017
3COVID-19
02/2022 - 01/2020
3Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2016
3Disease Progression
01/2021 - 01/2019
3Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 01/2020
3Hypersensitivity (Allergy)
01/2021 - 06/2020
3Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 01/2016
3Lymphatic Metastasis
01/2020 - 04/2013
3Respiratory Sounds (Crackle)
08/2019 - 10/2007
3Carcinoma (Carcinomatosis)
01/2019 - 04/2004

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2006
16Messenger RNA (mRNA)IBA
01/2022 - 01/2011
15Long Noncoding RNAIBA
04/2022 - 01/2016
13Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2012
10ManganeseIBA
02/2022 - 12/2016
10Biological ProductsIBA
01/2022 - 01/2016
9ResveratrolIBA
02/2022 - 12/2011
9MicroRNAs (MicroRNA)IBA
01/2021 - 03/2011
8CytokinesIBA
10/2021 - 06/2011
7Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022 - 05/2012
7DNA (Deoxyribonucleic Acid)IBA
01/2021 - 10/2007
7InterleukinsIBA
11/2020 - 07/2010
7Caspase 6IBA
01/2019 - 01/2012
6Therapeutic UsesIBA
11/2022 - 04/2013
6Interleukin-17 (Interleukin 17)IBA
06/2022 - 07/2010
6Small Interfering RNA (siRNA)IBA
03/2022 - 04/2009
6RNA (Ribonucleic Acid)IBA
01/2022 - 09/2015
6atezolizumabIBA
10/2021 - 06/2018
6Amyloid (Amyloid Fibrils)IBA
02/2020 - 04/2006
5Glucose (Dextrose)FDA LinkGeneric
03/2022 - 05/2015
5VaccinesIBA
12/2019 - 12/2011
5EnzymesIBA
01/2019 - 02/2012
4Pharmaceutical PreparationsIBA
01/2022 - 01/2019
46-methyladenineIBA
01/2022 - 01/2019
4Peptides (Polypeptides)IBA
12/2021 - 04/2006
4ErbB Receptors (EGF Receptor)IBA
04/2021 - 03/2014
4Phosphatidylinositols (Phosphatidylinositol)IBA
01/2021 - 10/2008
4CaspasesIBA
12/2020 - 06/2006
4Tyrosine Kinase InhibitorsIBA
01/2019 - 03/2014
4Interferon-gamma (Interferon, gamma)IBA
01/2019 - 12/2011
4Insulin-Like Growth Factor I (IGF-1)IBA
10/2015 - 04/2013
3Oxygen (Dioxygen)IBA
03/2022 - 08/2019
3Anti-Bacterial Agents (Antibiotics)IBA
03/2022 - 01/2012
3Sirtuin 1IBA
02/2022 - 01/2021
3InterferonsIBA
01/2022 - 04/2014
3Estrogens (Estrogen)FDA Link
11/2021 - 11/2013
3Antiviral Agents (Antivirals)IBA
01/2021 - 08/2012
3Small Nucleolar RNA (snoRNA)IBA
01/2021 - 01/2019
3B7-H1 AntigenIBA
01/2021 - 06/2018
3Carboplatin (JM8)FDA LinkGeneric
01/2021 - 01/2019
3Sirtuin 3IBA
01/2021 - 11/2019
3LipopolysaccharidesIBA
07/2020 - 01/2020
3Co-Repressor ProteinsIBA
02/2020 - 10/2018
3C-terminal binding proteinIBA
02/2020 - 10/2018
3Cadherins (E-Cadherin)IBA
02/2020 - 06/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 01/2011
3Bevacizumab (Avastin)FDA Link
01/2020 - 06/2018
3Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 01/2018
3Carrier Proteins (Binding Protein)IBA
01/2019 - 01/2011

Therapy/Procedure

20Therapeutics
08/2022 - 09/2012
10Drug Therapy (Chemotherapy)
01/2022 - 08/2013
5Lymph Node Excision (Lymph Node Dissection)
01/2022 - 08/2016
5Immunotherapy
01/2022 - 01/2019
4Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2022 - 01/2018
3Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
05/2022 - 01/2022
3Lasers (Laser)
03/2022 - 01/2017